TD Private Client Wealth LLC Has $2.08 Million Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

TD Private Client Wealth LLC lifted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 8.1% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 3,988 shares of the medical equipment provider’s stock after acquiring an additional 299 shares during the period. TD Private Client Wealth LLC’s holdings in Intuitive Surgical were worth $2,082,000 at the end of the most recent reporting period.

A number of other institutional investors also recently modified their holdings of ISRG. M.E. Allison & CO. Inc. bought a new stake in Intuitive Surgical during the 4th quarter valued at $449,000. Seilern Investment Management Ltd bought a new stake in Intuitive Surgical during the 4th quarter valued at $82,517,000. Sycomore Asset Management increased its stake in Intuitive Surgical by 27.4% during the 4th quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider’s stock valued at $9,214,000 after purchasing an additional 4,079 shares in the last quarter. Exome Asset Management LLC increased its stake in Intuitive Surgical by 16.8% during the 3rd quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock valued at $3,649,000 after purchasing an additional 1,069 shares in the last quarter. Finally, China Universal Asset Management Co. Ltd. increased its stake in Intuitive Surgical by 5.6% during the 4th quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider’s stock valued at $5,138,000 after purchasing an additional 525 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, EVP Brian Edward Miller sold 8,900 shares of the company’s stock in a transaction dated Tuesday, March 11th. The shares were sold at an average price of $485.07, for a total transaction of $4,317,123.00. Following the sale, the executive vice president now directly owns 5,758 shares of the company’s stock, valued at $2,793,033.06. This represents a 60.72 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, EVP Robert Desantis sold 11,545 shares of the company’s stock in a transaction dated Thursday, March 13th. The shares were sold at an average price of $499.22, for a total transaction of $5,763,494.90. Following the sale, the executive vice president now directly owns 5,224 shares in the company, valued at approximately $2,607,925.28. This trade represents a 68.85 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 33,754 shares of company stock valued at $17,691,621 over the last three months. 0.90% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

ISRG has been the subject of a number of recent research reports. Evercore ISI boosted their price target on shares of Intuitive Surgical from $490.00 to $530.00 in a research note on Monday, January 27th. Robert W. Baird decreased their price target on shares of Intuitive Surgical from $707.00 to $600.00 and set an “outperform” rating for the company in a research note on Tuesday, March 18th. UBS Group boosted their price target on shares of Intuitive Surgical from $500.00 to $560.00 and gave the company a “neutral” rating in a research note on Monday, January 27th. Barclays upped their target price on shares of Intuitive Surgical from $610.00 to $674.00 in a research note on Monday, January 27th. Finally, Morgan Stanley upgraded shares of Intuitive Surgical from an “equal weight” rating to an “overweight” rating and upped their target price for the stock from $522.00 to $650.00 in a research note on Monday, December 2nd. One investment analyst has rated the stock with a sell rating, five have given a hold rating and fifteen have given a buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $611.86.

Intuitive Surgical Stock Up 0.1 %

NASDAQ ISRG opened at $492.49 on Friday. The company has a market cap of $175.41 billion, a PE ratio of 76.83, a price-to-earnings-growth ratio of 5.85 and a beta of 1.43. Intuitive Surgical, Inc. has a 52 week low of $364.17 and a 52 week high of $616.00. The firm’s 50-day simple moving average is $562.24 and its two-hundred day simple moving average is $531.67.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.